Ascend Capital’s Regulus Therapeutics RGLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q3
$207K Sell
8,758
-145
-2% -$3.43K 0.01% 162
2018
Q2
$705K Buy
8,903
+556
+7% +$44K 0.03% 170
2018
Q1
$718K Sell
8,347
-103
-1% -$8.86K 0.03% 196
2017
Q4
$1.05M Buy
+8,450
New +$1.05M 0.04% 191